Hem / Studier & Dokumentation Femarelle

Studier & vetenskaplig dokumentation

Ladda ner pdf:er eller läs dokumenten direkt på skärmen

Clinical-and-Experimental-Obstetrics-Gynecology.-200431-2-123-6.

” …significant reduction in the Kupperman index following 12 weeks of treatment, which was sustained throughout the 12 months of treatment.”

 

Menopause.-200310-6-522-5

“Femarelle treatment in postmenopausal women increases BMD without unwanted estrogenic effect.”

 

Journal-of-Steroid-Biochemistry-Molecular-Biology.-200698-1-90-6

“DT56a … unique nature compared to the compounds currently used for postmenopausal osteoporosis by being bone-forming and not only an anti-resorptive agent.”

 

Climacteric-2015.18-6-813-6

“Treatment with DT56a resulted in a significant reduction in the number and intensity of hot flushes in postmenopausal women… observed within the first month of treatment.”

 

BJOG.-2005112-7-981-5

“DT56a prevents postmenopausal osteoporosis.”

 

Menopause.-2011-Mar-18-3-285-8

“Femarelle … inhibits menopausal symptoms without thrombogenicity…”

 

NAMS-Annual-Congress-2011-book-of-abstracts

” DT56a was effective against symptomatic vulvo-vaginal atrophy (vaginal dryness)…”

 

J-Endocrinological-Investigation-201336-7-521-6

“DT56a decreased menopausal symptoms significantly and in the same degree as HT.”

Femarelle SV

Du använder en gammal webbläsare

Gamla webbläsare har bara delvis stöd för ny teknik och ger inte webbplatsen en ärlig chans att leva upp till sin fulla potential. Du kan enkelt ladda ner en annan webbläsare som fungerar bättre. Här är ett axplock moderna webbläsare som fungerar bra!

Uppdatera min webbläsare

Jag vill fortsätta ändå